Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
PTI-125 is a purported binding agent of filamin A, a cytoskeletal protein said to stabilize the interaction between amyloid-β (1-42) (Aβ42) and the α7 nicotinic acetylcholine receptor (nAChR).1,2 PTI-125 reportedly binds to filamin A to reverse an aberrant conformational change induced by Aβ42, which prevents and reverses Aβ42-α7 nAChR binding and improves neuropathological outcomes in the 3xTg mouse model of Alzheimer’s disease. However, the data regarding PTI-125 have prompted expressions of concern by the journals in which the data were published.
WARNING This product is not for human or veterinary use.
1. Expression of concern: Wang et al., "Reducing amyloid-
2. PTI-